FisherVista
@fishervista
24176 articles
Articles

Cryptocurrency Market Shows Stability Amid Traditional Equity Volatility
The cryptocurrency market is holding near a $2.32 trillion market capitalization, showing little change compared with last week. This stability stands out at a time when traditional equities have struggled, with the Nasdaq-100 shedding roughly 5% over the same period.Crypto mining entities like BitFuFu Inc. are likely to wa...
April 2, 2026Read the full article

Olenox Industries Stockholders Approve Corporate Actions, Reject Merger at Annual Meeting
Olenox Industries announced that stockholders approved multiple corporate actions during the company's annual meeting held on March 31, 2026. The approved measures included the election of directors, ratification of the independent auditor, advisory approval of executive compensation, several share issuance proposals, and a...
April 2, 2026Read the full article

RocketDocs 2.66.0 Release Introduces Bulk Team Assignment to Accelerate Proposal Response Workflows
RocketDocs, a response management platform for proposals and other questionnaires, announced the release of version 2.66.0, introducing bulk team assignment capabilities. This new feature allows knowledge management teams to instantly scale project collaboration, reducing manual administrative overhead.
April 2, 2026Read the full article

Oncotelic Therapeutics Partners with TechForce Robotics to Advance AI-Enabled Pharmaceutical Manufacturing Platform
Oncotelic Therapeutics, Inc. (OTCQB: OTLC) has entered a strategic partnership with TechForce Robotics to advance commercialization of its AI-enabled, GMP-compliant robotics platform designed for pharmaceutical manufacturing and regulated environments. The integrated system combines Oncotelic's proprietary artificial intell...
April 2, 2026Read the full article

Xeriant Receives U.S. Patent Allowance for Fire-Resistant Composite Technology
The U.S. Patent and Trademark Office has issued a Notice of Allowance to Xeriant, Inc. (OTCQB: XERI) for its patent covering a proprietary multilayered fire-resistant composite and manufacturing method. This development marks a key milestone for the company's DUREVER materials platform, which includes NEXBOARD composite wal...
April 2, 2026Read the full article

Ucore Rare Metals Advances North American Rare Earth Processing Amid Global Supply Concerns
The global rare earth elements market faces significant supply chain challenges as demand for these critical materials continues to accelerate, particularly for clean-energy technologies where industry analysts project two to three times growth by 2040. Ucore Rare Metals Inc. (TSX.V: UCU) (OTCQX: UURAF) is positioning itsel...
April 2, 2026Read the full article

Thousands to Receive Hands-Only CPR Training at NFL Draft in Pittsburgh
When cardiac arrest strikes, immediate CPR can double or even triple a person's chance of survival, yet more than half of people who collapse outside a hospital do not receive it. To help close that gap, the American Heart Association and the National Football League, along with Damar Hamlin's Chasing M's Foundation, will w...
April 2, 2026Read the full article

Wheaton Precious Metals Completes $4.3 Billion Silver Stream Agreement for Peru's Antamina Mine
Wheaton Precious Metals Corp. has completed a significant silver streaming transaction with BHP related to the Antamina mine in Peru, representing one of the largest streaming deals in the precious metals industry. The agreement involves a $4.3 billion upfront payment from Wheaton to secure rights to 33.75% of payable silve...
April 2, 2026Read the full article

Soligenix's HyBryte Shows Superior Efficacy and Safety Over Valchlor in Cutaneous T-Cell Lymphoma Treatment
The publication of positive results from Soligenix Inc.'s comparability study in Oncology and Therapy represents a significant development for patients with cutaneous T-cell lymphoma, a rare form of non-Hodgkin lymphoma that affects the skin. The study directly compared HyBryte (synthetic hypericin sodium) against Valchlor,...
April 2, 2026Read the full article

Planet Ventures Invests $250,000 in AI-Driven Space Software Company Antaris
Planet Ventures Inc. (CSE: PXI) (OTC Pink: PNXPF) (FSE: P6U) has announced a strategic investment of $250,000 in Antaris, an emerging leader in AI-driven space mission software. This investment follows the first close of Antaris's $28 million Series A financing round, providing Planet Ventures with exposure to a high-growth...
April 2, 2026Read the full article

NurExone Biologic Wins Healthcare Award, Expands Investor Outreach Strategy
NurExone Biologic Inc. has received first place in the Healthcare category at the BOLD Awards VII Gala held in Barcelona on March 27, 2026. The award recognizes the company's leadership in developing exosome-based therapies for central nervous system injuries. This recognition by a panel of global industry leaders underscor...
April 2, 2026Read the full article

American Fusion Nears Critical Fuel Supply Agreements for Aneutronic Fusion Technology
American Fusion Inc. (OTC: AMFN) is in the final stages of securing multi-year supply agreements with a U.S.-based subsidiary of a global industrial organization for helium-3 and deuterium, key fuels for its Texatron aneutronic fusion system. This development represents a significant step toward establishing the supply chai...
April 2, 2026Read the full article

MAX Power Mining Reports Significant Progress in Saskatchewan Natural Hydrogen Exploration
MAX Power Mining Corp. reported substantial progress in developing its Saskatchewan-based natural hydrogen portfolio, with recent achievements including successful drilling at the Bracken Well and completion of a high-resolution 3D seismic survey at the Lawson Discovery area. The company also identified a new Lawson-style t...
April 2, 2026Read the full article

Lantern Pharma to Demonstrate AI Co-Scientist Platform in April Investor Briefing
Lantern Pharma announced it will host an investor, analyst and shareholder briefing on April 9, 2026, featuring a live demonstration of withZeta.ai, described as the first multi-agentic AI co-scientist for rare cancer drug discovery, development and clinical trial design. The event will highlight the platform's capabilities...
April 2, 2026Read the full article

Lantern Pharma to Demonstrate AI Co-Scientist Platform for Rare Cancer Drug Development
Lantern Pharma announced it will host an investor, analyst and shareholder briefing on April 9, 2026, featuring a live demonstration of withZeta.ai, described as the first multi-agentic AI co-scientist for rare cancer drug discovery, development and clinical trial design. The webcast will highlight the platform's capabiliti...
April 2, 2026Read the full article

Datavault AI Partners with Demora Foundation to Tokenize K-Entertainment Assets
Datavault AI Inc. (NASDAQ: DVLT) has entered into a Technology Integration Agreement with Demora Foundation, positioning itself as the formal AI data intelligence and real-world asset (RWA) tokenization technology partner for the K-Entertainment & K-Wave Global Platform. This partnership targets the substantial economic eco...
April 2, 2026Read the full article

Nevada Organic Phosphate Targets Fertilizer Supply Gap for Growing Organic Agriculture Market
The organic agriculture sector faces a significant challenge in scaling production to meet growing consumer demand, with one of the most difficult inputs to secure being phosphate fertilizer that complies with organic certification standards. Nevada Organic Phosphate Inc. (CSE: NOP) (OTCQB: NOPFF) is positioning its Murdock...
April 2, 2026Read the full article

California Taxpayer-Funded Therapy Receives FDA Approval for Rare Childhood Disease
The U.S. Food and Drug Administration has granted accelerated approval to KRESLADI, a one-time therapy developed by Rocket Pharmaceuticals to treat severe leukocyte adhesion deficiency-I in children without bone marrow donor matches. This marks the first approved therapy to emerge from California taxpayer funding through th...
April 2, 2026Read the full article

Sigyn Therapeutics Launches Initiative to Evaluate Medical Technologies for CTE in Former NFL Players
Sigyn Therapeutics, Inc. has announced the launch of an initiative to evaluate emerging medical technologies in former NFL players at risk of chronic traumatic encephalopathy (CTE). Former NFL players experience significantly higher rates of neurodegenerative diseases compared to the general population, including amyotrophi...
April 2, 2026Read the full article

CHARBONE Expands Helium Distribution in Ontario Amid Global Supply Constraints
CHARBONE Corporation has refilled a dedicated helium trailer to serve an existing customer in Ontario, confirming the commercial continuity of its Helium division launched in 2025. This operation aligns with the company's strategy to build an integrated platform for distributing strategic industrial gases across North Ameri...
April 2, 2026Read the full article

ORGANA International Expands Access to Plant-Derived Mineral Drink Through OneLavi Platform
Plant-derived mineral drink with fulvic acid now accessible on OneLavi, supporting daily wellness routines.
April 2, 2026Read the full article
